The discovery that HAE patients were deficient in C1 inhibitor (C1INH) quickly led to the subsequent discovery that the protein could either be nonsecreted (Type I HAE) or dysfunctional (Type II HAE). This evidence concerns the gene SERPING1 and hereditary angioedema.